Showing results (31-40 of 240) with videos related to
Sort By:
Pageof 24
Peptides|May 1, 1984
Endogenous benzodiazepine ligands in human cerebrospinal fluidJ Deckert, W Kuhn, H PrzuntekFortschritte Der Medizin|May 20, 1997
[Non-motor symptoms of Parkinson disease. Significant impact on quality of life--using possible treatments]T Müller, W Kuhn, H PrzuntekJournal of the Neurological Sciences|December 2, 2000
Choice reaction time after levodopa challenge in parkinsonian patientsT Müller, S Benz, H PrzuntekEuropean Neurology|January 1, 1995
Alterations in chromatic contour perception in de novo parkinsonian patientsT Büttner, W Kuhn, H PrzuntekJournal of Neurology|January 1, 1984
On the exchange of H2O/D2O molecules across membranes of erythrocyte ghosts from patients with Huntington's disease and from normal individualsH Vigenschow, H Przuntek, R LawaczeckActa Neurologica Scandinavica. Supplementum|January 1, 1989
The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPG, HIAA and HVA levels in the cerebrospinal fluidH Przuntek, W Kuhn, P KrausPharmacopsychiatry|February 3, 2006
Transdermal rivastigmine treatment does not worsen impaired performance of complex motions in patients with Alzheimer's diseaseS Muhlack, H Przuntek, T MüllerNeurosurgical Review|January 1, 1990
Glossopharyngeal neuralgia associated with an autoimmune disorder of the thyroid gland. Case reportR Karwasz, K Berger, H PrzuntekJournal of Neural Transmission|January 1, 1986
Determination of beta-endorphin and substance P in small volumes of human cerebrospinal fluidK Henning, T M Wallasch, H PrzuntekEuropean Neurology|January 1, 1986
Spin label study of red blood cell membranes in Huntington's diseaseP H Kraus, H Vigenschow, H PrzuntekPageof 24